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ABSTRACT 
DNA PLASMID PURIFICATION PROCESS OPTIMIZATION 
AT LIFE TECHNOLOGIES CORPORATION 
Trevor Shepherd 
 
This project focused on optimizing the plasmid DNA purification process at Life 
Technologies.  These plasmids are designed to code for specialized proteins used by 
research universities, national laboratories, or research companies.  Once cultivated 
and harvested, the plasmids must be analyzed for quality and quantity. The project is 
divided into improving three aspects of the process: 1) plasmid identification, 2) plasmid 
purity evaluation, and 3) process yield.  Plasmid identification is now simpler, more 
robust and has zero ambiguity.  Plasmid purity evaluation is now measured with 
computer software, which reduces user error and eliminates subjectivity.  Using the 
nascent metrics provided by the improved identification and purity evaluation 
techniques, process yield was analyzed and improved.  The hypotheses on yield 
improvement and the information gleaned from their resulting experiments provide a 
foundation for further process improvement. 
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I.  Introduction 
Life Technologies Synopsis   
Life Technologies is a life science tools company which employs approximately 
11,000 people, holds approximately 4,000 patents, and markets over 50,000 
products.  The company’s list of products can be divided into two basic 
categories: consumables and diagnostics.   
The consumable products are specifically designed DNA, RNA and proteins. 
These are typically used by research universities, national laboratories, or 
research companies as the basic materials for investigating diseases, 
pharmacology, tissue engineering and genetic engineering.  The diagnostic 
products are the tools used to manipulate and evaluate utilization of the 
consumable products.  Some of Life Technologies’ most notable diagnostic 
products are: Ion Torrent®, which utilizes a state-of-the-art technology to rapidly 
sequence genetic code; Dynabeads®, which uses magnetic and surface 
properties to separate cells; and Purelink® Separation Products, which automate 
the multi-step processes of isolating DNA or RNA.   
The size and scope of Life Technologies evolved through numerous mergers and 
acquisitions over the last 30+ years, resulting in a strategic amalgamation of both 
complimentary and competing companies.  While the succession of coalescing 
companies has been successful, each nascent product acquisition requires a re-
worked production process to efficiently incorporate it into the aggregate. 
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Project Overview 
This project focuses on optimizing Life Technologies’ in-house DNA Plasmid 
Manufacturing Process.  A plasmid is a small circle of DNA which can replicate 
independently of the host cell chromosome.  Typically, this DNA has been 
ordered by a customer for the production of a desired recombinant protein.  
These recombinant proteins have been molecularly cloned from their natural 
source, typically bacteria, and engineered for specific expression systems. 
When researching proteins, it is extremely useful to modify them so they are 
easily identified and separated.  These strategies are effected by designing DNA 
into the plasmids which code for resistance to an antibiotic, and/or for a particular 
tag.   
A simple yet effective way of separating a desired host-cell type from an 
undesired host-cell type is to destroy the undesired cells with an antibiotic.  
Implementation of this strategy involves proliferation in a medium containing an 
antibiotic.  Any cell not containing the DNA that codes for protection against the 
antibiotic will be destroyed.   
DNA designed to code for particular tags allow separation/identification at the 
protein level.  Protein tags are genetically grafted onto the recombinant protein of 
interest.  Two of the most common types of tags are epitope and fluorescence; 
these tags create high antibody affinity and enable fluorescent illumination, 
respectively. 
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Once a plasmid is designed, it must be proliferated in a cell culture and purified.  
The basic outline of the DNA purification process follows these steps: 1) obtain 
the desired plasmid; 2) transform the plasmid into a specialized strain of E. coli 
bacteria; 3) proliferate the transformed bacteria; 4) harvest the desired DNA; and 
5) analyze and verify the DNA identity, purity and concentration.  Steps 4 and 5 
needed the most improvement and are where the majority of the project was 
focused.   
 
Technical Background 
Step 1: Obtain Plasmid  
Life Technologies categorically stores hundreds of plasmids, recombinant DNA 
designed to produce specific complimentary combinations of proteins.  These 
stored plasmids are referred to as “Glycerol Stock”, and are stored in a mixture of 
glycerol and TE Buffer (TE) at -80°C.  The mixture safely stores the plasmids by 
maintaining the appropriate pH of approximately 8.0, chelating the metal ions that 
activate degrading nucleases, and it does not crystallize at this temperature 
which greatly reduces shear stress on the DNA.   
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Figure 1.  Storage Freezer.  Plasmids contained in mini-tubes and stored in 
categorically organized boxes in a -80°C freezer. 
 
  
Figure 2.  Individual “Glycerol Stock” On Ice.  These Mini-tubes contain the 
stored plasmid suspended in glycerol and TE buffer.  The DNA is kept cold to 
reduce molecular interaction which prevents degradation. 
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Figure 3.  Plasmid Map.  Example of Life Technologies’ visual depiction of a 
plasmid. 
 
The map shows the regions where specified proteins are coded, the number of 
base pairs, and the restriction enzyme recognition sites.   
 
Step 2: Plasmid Transformation 
Once the plasmid has been selected, it must be transformed into a cell for 
proliferation and then harvested from the bacteria culture.  The bacteria cell wall 
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is the biggest barrier to DNA uptake.  To pass the cell wall, a modified non-
infectious strain of E. coli bacteria is mixed with the plasmid in saline solution.  
The mixture is then heated to 42°C, causing the wall of the cell to become porous 
enough for the plasmid to enter.  Once transformed, the plasmid can be 
multiplied within the cell independently of the bacteria genome because it 
contains its own origin of replication. 
 
 
Figure 4.  Diagram of Transformation.  This illustration depicts the incorporation 
of a recombinant bacteria plasmid into a host cell. 
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Figure 5. Plasmid Transformation Station.  This is the warm water bath (42°C) 
where transformation occurs. Hosts are briefly “shocked” by the warm water 
allowing the plasmid to enter the cell.  Once incorporated, the cell has the 
molecular framework to facilitate proliferation of the plasmid in addition to its own 
genomic DNA. 
 
Step 3: Proliferating the Transformed Bacteria 
The bacteria transformed with the plasmid of interest are then smeared onto an 
agar plate in a petri dish and incubated for 12 hours.  The agar provides a 
suitable growth environment and contains the appropriate antibiotic.  After 
incubation, individual colonies appear on the agar where a successfully 
transfected bacteria has proliferated.  The antibiotic destroys all cells which have 
not incorporated the plasmid of interest and its constituent antibiotic resistance 
gene. 
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Figure 6.  Illustration of Antibiotic Resistance Selection.  This is a very effective 
way of easily distinguishing between successfully and unsuccessfully 
transformed bacteria cells.   
 
A sample from a successfully transformed bacteria colony is taken and used to 
progenerate a larger quantity of the plasmid of interest. 
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Figure 7.  Petri Dish with Transformed Bacteria Colonies. 
 
Next, the transformed bacteria are transferred into a test tube with growth media 
and antibiotic, and then swirled for 12 hours.  The combination of growth media 
containing amino acids and sugars, and a continuous swirl provides the 
necessary building blocks, energy, and shear stimulation for proliferation.   
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Figure 8. New Brunswick C-24 Incubator and Shaker.  This machine contributes 
to an ideal growth environment by maintaining the proper temperature and 
shaking the samples. 
 
The bacteria culture is then scaled-up one more time by transferring the test tube 
contents into 1L Erlenmeyer flasks and then proliferated in a larger ideal growth 
environment.   
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Figure 9. Large Scale Inoculation.  The Innova 4 provides a very similar 
environment as the New Brunswick C-24, but it is designed to shake 1L flasks 
instead of test tubes. 
 
Step 4: Harvesting DNA 
Once the transformed bacteria are proliferated to an adequate level, appropriate 
steps must be taken for safe and effective separation of the desired plasmid from 
the rest of the cell.  First, the bacteria are separated from the growth media by 30 
minutes of high speed centrifugation with a radial acceleration of 4,500 times that 
of gravity.   
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Figure 10. Sorvall RC3B Centrifuge.  This centrifuge is used to spin down the 
bacteria and, later in the process, the purified DNA. 
 
 
Figure 11.  Bacteria Pellet.  Pellets of bacteria stuck to the side of the container 
and growth media.  The resulting pellet of bacteria is separated by carefully 
pouring off the growth media.   
 
Next, the pellet is suspended in a solution of lysis buffer and ribonucleases which 
destroys the cell wall and degrades the newly exposed RNA, respectively.  After 
a few minutes of gentle agitation, the lysate and ribonucleases are deactivated 
with a neutralization buffer.  The buffer also precipitates the cell debris, proteins, 
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genomic DNA and lysate.  This mixture is first pulled through a filtration cartridge 
which removes the precipitated material.  The residual aqueous solution of 
dissolved RNA and DNA is then pulled through a binding cartridge.   
 
Figure 12.  Filtration and Purification Station.  The solution is poured in the top 
container of the apparatus and a vacuum is attached to the bottom canister to 
facilitate flow through the filtration or binding cartridge.  This setup is used for the 
cell debris filtering cartridge and the RNA and DNA binding cartridge.  
 
The binding cartridge is composed of a positively charged resin which binds the 
negatively charged DNA and RNA molecules.  Once the solution has passed 
through the cartridge and the DNA and RNA has been bound, a salty wash buffer 
is run through the cartridge twice, disrupting the electrical attachment of the 
nucleotides.  The first wash of salt solution disrupts the loosely bound RNA which 
is captured in a beaker and discarded.  The second wash removes the more 
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tightly bound DNA molecules from the resin and is captured in another beaker.  
At this point, the plasmid DNA is relatively free from RNA and protein 
contaminants; however, one more step is taken for further purification.  The 
plasmid DNA is then precipitated with isopropanol, washed with 80% ethanol and 
centrifuged into a pellet.  Finally, the DNA pellet is suspended in TE buffer which 
maintains an ideal pH and protects against degradation. 
 
Figure 13.  DNA Pellet.  Centrifugation of the suspended DNA packs the DNA 
into a pellet enabling easy separation from the media. 
  
Step 5: Analyzing and Verifying the DNA Identity, Purity and Concentration 
Once the plasmid DNA has been purified, a small sample is taken to evaluate the 
amount of DNA yielded by the process.  This is accomplished using a 
spectrophotometer.  The spectrophotometer evaluates concentration of DNA 
based on the amount of light absorbed by the sample.  Light is emitted at 260nm, 
which is the wavelength DNA absorbs, and the instrument calculates a 
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concentration based on the amount of light that passes through (not absorbed) 
the sample relative to a blank sample. 
 
  
Figure 14. Nanodrop Spectrophotometer.  1-2 µL of purified plasmid is pipetted 
onto the Nanodrop to evaluate the DNA concentration. 
 
Once the DNA concentration has been determined, it must be evaluated for 
purity and positively identified. To accomplish this, the purified DNA is digested 
by a set of restriction enzymes and then electrophoresed to separate the different 
pieces of DNA molecules based on size and shape.   
A restriction enzyme, a particular type of endonuclease, cuts the backbone by 
catalyzing the hydrolysis of the phosphodiester bonds at specific sequences of 
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nucleotides.  These specific sequences are known as recognition sites, most of 
which are palindromic and six nucleotides long.   
 
Figure 15.  Restriction Enzyme Reaction.  The breaking of the phosphodiester 
bonds of the DNA backbone is a result of a nucleophilic attack by the enzyme 
complex on the electrophilic phosphorous atom. 
 
Knowing the sequence of a purified plasmid and the recognition sites for many 
restriction enzymes allows the plasmid to be cut into predictable lengths.  With 
this knowledge, Life Technologies designed their restriction digests by pairing 
plasmids with a specific group of restriction endonucleases.  The expected 
lengths of DNA can be compared to the actual DNA strands resulting from the 
digest as a means of identifying the plasmid sequence. 
Using this technique, a sample of the plasmid, digested by restriction enzymes, is 
pipetted into multiple wells in an electrophoresis gel.  During electrophoresis, an 
electric field is set up across the gel box.  Over time the negative DNA molecules 
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move through the gel towards the positive side.  The smaller molecules are able 
to move more quickly through the gel creating a method of separation based on 
size.   
 
Figure 16.  Electrophoresis Gel Box.  The electric field is set up so that the 
negatively charged DNA starts on the negative end of the box.  Negatively 
charged molecules then travel toward the positive side at rates proportional to 
their size. 
 
Once the electrophoresis is complete, the agar gel and DNA are stained with 
ethidium bromide (EtBr).  EtBr binds with the DNA and moves in between its 
hydrophobic base pairs which stretches the DNA fragment and removes water 
molecules from the ethidium cation. The result of this dehydrogenation is an 
increase in fluorescence of the ethidium. 
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Figure 17.  DNA Electrophoresis Gel.  The column on the left is called the ladder.  
The columns to the right are DNA molecules. Each line of the ladder corresponds 
to a different size molecule with the lines closest to the bottom being the smallest 
molecules.  The ladder provides a way of indirectly measuring the size of the 
pieces of cut DNA. 
 
The purity of the DNA can be determined by comparing the amount of Genomic 
DNA, which is large and travels the shortest distance, to the Plasmid DNA.  This 
ratio of Genomic DNA over total DNA (Genomic plus Plasmid DNA) is presented 
as a percent purity.  The amount of plasmid DNA as a percent of total DNA can 
then be multiplied by the concentration to determine the amount of Plasmid DNA. 
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Shortcomings of DNA Purification and Analysis 
The end product is sold at a specific concentration of plasmid DNA, so the 
product must be well characterized during manufacturing to accurately market 
the product.  The lack of precision in the separation and purification of the 
plasmid DNA from the genomic DNA and cell debris resulted in decreased yield 
and a lack of purity.  The final step of confirming the correct identity of the 
plasmid and the level of purity were also in need of improvement.  The identity 
confirmation was inconclusive, and the purity check was subjective.  In order to 
improve the end product, both the harvesting and yield analysis steps of the 
process were investigated for improvement. 
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II.  Objectives and Approach 
There were three fundamental objectives: 1) improve the conclusiveness of the 
plasmid identification protocol, 2) reduce the ambiguity of the plasmid purity 
evaluation protocol, and 3) improve the purity and yield of the plasmids with 
regard to genomic DNA. 
 
Improving the Identification Protocol 
The pre-existing identification protocol was inherently inconclusive and had an 
unacceptably high rate of returning a false negative.  It utilized a set of restriction 
enzymes to cut the strand of plasmid DNA at multiple locations.  The restriction 
digest product was then electrophoresed, and the lengths of the resulting strands 
of DNA were compared to the expected lengths. If they all matched, the plasmid 
was identified as correct.   
There were a few problems with this technique: the restriction enzymes being 
used were highly susceptible to damage during storage which results in 
unpredictable behavior; some of the cut sites were highly susceptible to 
methylation which blocks the enzyme from cutting the DNA; and the inherent 
possibility that an incorrect plasmid could coincidentally yield the expected 
lengths of DNA strands.  To improve the identification step, an entirely new 
protocol was developed. 
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The new identification protocol sequences the manufactured plasmid and then 
compares the sequence of nucleic acids unique to that plasmid, approximately 
300 long, to what the sequence is supposed to be.  The result is a direct 
comparison, one nucleic acid at a time, of the manufactured plasmid against the 
correct sequence, resulting in an unequivocally conclusive test.  To implement 
this new protocol, a unique region of each plasmid had to be determined, a 
database of each plasmid and its identification sequence developed, and a 
method for sequencing and comparison installed. 
 
Improving the Purity Analysis Protocol 
The pre-existing protocol, which analyzed the percent genomic DNA in the 
purified sample, was highly subjective.  The protocol called for the purified DNA 
to be electrophoresed in an agar gel, and then stained with EtBr.  Because the 
strand of plasmid DNA is much smaller than genomic DNA, the two molecules 
travel at different rates during electrophoresis and are thus separated.  A picture 
of the stained gel was taken under ultraviolet light, and an operator then made a 
subjective assessment of the purity by comparing the extent to which EtBr was 
bound to each type of DNA molecule.  Because of the subjective nature of this 
protocol, the purity evaluation was neither precise nor reproducible. 
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Figure 18. Previous Electrophoresis Gel. An image of an electrophoresis gel 
used in the pre-existing purity protocol.  DNA banding is imprecise. 
 
One of the objectives of this project was to develop a new purity protocol utilizing 
software that essentially quantifies the luminescence of the stained DNA, which 
is directly proportional to the amount of DNA. 
 
Improving the yield of the Purification Process 
Until the reproducibility of the purity evaluation technique was improved, the 
purity and yield of the entire purification process could not be evaluated for 
improvement.  Once the process could be accurately evaluated for purity, the 
correct yield could also be determined.  With that metric now available, a 
strategic plan of investigation was developed to specialize the purification 
process for each plasmid. 
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III. Methods and Materials 
Improving the Identification Protocol  
Once the plasmid has been purified, it is important to verify its identity.  The pre-
existing method was inconclusive and its components were prone to 
malfunctioning.  The new method provides a decisive evaluation of each 
nucleotide by sequencing the DNA in a region of the plasmid that is uniquely its 
own.   
To achieve this, a sample of the purified plasmid of interest is sent to a local 
genetic sequencing company where the identifying DNA is sequenced.  But first, 
a region to be sequenced must be identified.  Determining the region appropriate 
for confirming the plasmid’s identify was the first step to improving the 
identification process.  
Life Technologies holds a database with the nucleotide sequence for each 
plasmid of interest.   
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Figure.  19.  Raw Plasmid Sequence. An example of a plasmid sequence before 
it is entered into Vector NTI.  Analysis in this format without a bioinformatics 
program is tedius and inefficient. 
 
These sequences were transferred into a bioinformatics program called Vector 
NTI.  This software enables the search of specific sequences within the molecule 
so that genes, primer recognition sequences and enzyme recognition sites can 
be efficiently identified and labeled.  
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Figure 20. Vector NTI Pictorial of Plasmid.  The markers identify restriction 
enzyme recognition sites and regions that code for particular proteins.   
 
The majority of the plasmid’s genetic code is not unique to itself.  Most plasmids 
code for a multitude of proteins necessary to carry out basic cell life that are 
common amongst a group of similar cells.  The unique region of the plasmid that 
is used for its identification is called the Multiple Cloning Site (MCS).  The MCS is 
a synthetic region of the plasmid with a particularly high concentration of 
Plasmid A 
Plasmid A 
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restriction enzyme sites.  It enables a wide range of insert locations for a scientist 
designing new genes into a plasmid and is the location of the genetically 
engineered genes of interest.  Once the MCS is located, primer sequences on 
either side of it are identified for sequencing. 
 
Figure 21.  Life Technologies’ Product Manual Sequence Description.  This was 
used in concert with the Vector NTI map for primer design. 
 
With the identifying region located and the surrounding primers determined, the 
plasmid can be sent out for sequencing.   
The DNA is sequenced by separating the two phosphate-deoxyribose 
backbones, creating two single-stranded DNA molecuels.  The primers 
surrounding the region of interest then coordinate with their corresponding 
sequence of nucleic acids and catalze DNA Polymerase’s elongation of the 
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complimentary strand.  This is done in the presence of deoxyribonucleotide 
monomers (dNTP), the single units of a DNA strand, and a dideoxyribonucleotide 
triphosphate analog (ddNTP).   The ddNTP’s are dNTP’s with the 3’-OH group 
replaced with a 3’-H.  This substitution renders the ddNTP unable to form the 
phosphodiester bond between dNTPs, thus terminating elongation of the strand.   
 
 
Figure 22.  Molecular Structure Illustration.  An Illustration of the structural 
difference between deoxyadenosine triphosphate (dATP) and dideoxyadenosine 
triphosphate (ddATP). 
 
Four reactions are carried out in parallel, each with a different ddNTP: 
dideoxyadenosine triphosphate (ddATP), dideoxythymidine triphosphate 
(ddTTP), dideoxyguanosine triphosphate (ddGTP), and dideoxycytidine 
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triphosphate (ddCTP).  Each of the four reactions incorporates a different 
flourophore that modifies the corresponding ddNTP.  The four reactions are then 
run through an electrophoresis gel to determine molecular length and constituent 
nucleotides are identified according to light emission properties of the different 
fluorophores.  In this way a large population of randomly sized DNA molecules 
with a known number of base-pairs can be evaluated.  This process is highly 
automated allowing thousands of nucleotides to be identified in minutes.  The 
evaluation program then produces a read-out similar to the one below. 
 
Figure23.  Typical Sequencing Read-out.  Each colored peak corresponds to a 
specific wavelength and nucleotide.  The height of the peak is a representation of 
the strength of the nucleotide identity as determined by number of matches. 
 
With the DNA sequenced, the identity of the purified plasmid can be compared, 
nucleotide by nucleotide, to the correct sequence for conclusive positive 
identification.  Figures 24 and 25 illustrate how Vector NTI is used to compare 
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the actual plasmid DNA, as determined by the outsourced sequencing company, 
with the Identification Sequences in Life Technologies’ database. 
The ContigExpress application of Vector NTI compares the sequence identified 
by the outsourced sequencing company with the known Identification Sequence 
in Life Technologies’ database.   
 
Figure 24. ID Sequence Lay-out.  Pictorial representation of how sequenced 
DNA is spatially coordinated with the Identification Sequence in Life 
Technologies’ database.   
 
Each MCS has three versions (A, B and C), one for each place in the reading 
frame.  This allows for flexibility when designing the MCS into a particular 
plasmid.  Accordingly, there are three Identification Sequences per MCS per 
plasmid.  In Figure 24, the three bands in the middle correspond to the A, B and 
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C versions of the plasmid Identification Sequences.  Above are the 3 forward 
priming sequences (there is a duplicate of each for insurance resulting in a total 
of 6).  Below the Identification Sequences are the reverse priming sequences 
with the same redundancy as the forward priming sequences.  As illustrated, 
neither the forward nor the reverse priming sequence individually spans the 
entire Identification Sequence; but together, with some overlap, the entire 
Identification Sequence can be compared. 
 
Figure25.  ContigExpress.  An image of how ContigExpress compares the 
sequences in Figure 24 Nucleotide by nucleotide.  It is here that the 
determination of correct identification is made.  The highlighted discrepancies in 
the middle are due to the single and double nucleotide shifts of the A, B and C 
reading frames. 
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Improving the DNA Purity Analysis Protocol 
The first step was to change the type of electrophoresis gel used.  The pre-
existing protocol used Life Technologies’ E-Gel®, a prepackaged electrophoresis 
gel with a built-in ladder and its own electric field source.  These E-Gels, 
however, run too hot for our application, causing denaturation, which results in 
“smiling” of the DNA bands.  Smiling DNA decreases the readability and 
precision of the banding.  The E-Gels were replaced with hand-poured gels 
which run at an appropriate temperature and are more customizable.  The result 
is a more precise and reliable DNA banding pattern. 
 
Figure 26. E-Gel with “Smiley Faces”.  These pre-packaged electrophoresis gels 
used in the pre-existing protocol ran too hot.  This caused denaturation of the 
DNA resulting in “smiley face” bands.  The bands of the ladder are also distorted. 
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Figure 27.  Hand-Poured Gel.  These gels run at a more appropriate temperature 
and provide a higher degree of customization.  The result is a more precise DNA 
size gradation. 
 
With the hand-poured electrophoresis gels, the banding is more consistent, but 
the ambiguity of the purity analysis still needed to be removed.  To eliminate the 
subjective nature of the protocol, evaluation was changed from a visual 
assessment by a technician to pixel evaluation by computer software.  
A 2UV Transilluminator was used to capture an ultraviolet image of the gels.  
Then VisionWorksLS software was used to quantify the amount of each type of 
DNA based on the density of black and white pixels. 
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Figure 28. 2UV Transilluminator. 
 
 
Figure 29.  Density Box.  An example of the defined region used to evaluate the 
quantity of DNA in the band. 
 
After electrophoresis on the digested DNA is complete, the gels are stained with 
EtBr.  EtBr binds to the DNA and fluoresces when exposed to ultraviolet light 
from the 2UV Transilluminator.  The fluorescence of the gel is then captured by 
the 2UV Transilluminator and communicated to the VisionWorksLS imaging 
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software.  The imaging program enables the user to view the DNA bands and 
employ objective numerical evaluation techniques.    
 
 
Figure 30. VisionWorksLS Imaging Software Interface. 
 
Once captured by the viewing software, the electrophoresed banding patterns 
become readily apparent.  Each purified plasmid is electrophoresed into two 
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columns, one that has been digested by a restriction enzyme and one that has 
not been digested.   
 
 
 
Figure 31.  Electrophoresis Banding Pattern.  An illustration of typical 
electrophoresis banding patterns for digested and undigested plasmids. 
 
Nicked DNA 
Nicked DNA 
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The first column, starting from the left, of each pair contains the purified sample 
that has not been digested.  When the undigested purified plasmid is 
electrophoresed, 3 prominent bands show up.  The largest molecular band is the 
genomic contamination, which is essentially what the purity analysis is evaluating 
for.  The next largest band is nicked plasmid, or open circular DNA with one 
strand cut.  And the third band, the smallest molecule, is the supercoils of DNA.  
The electron micrograph image below is a helpful illustration of these three 
common conformations. 
 
Figure 32. Electron Micrograph Image of Bacterial DNA Plasmid. 
 
The second column contains the same purified plasmid as the first, but has been 
cut once by a restriction enzyme.  The predominate band in this column is the cut 
supercoil of DNA.  The cut plasmid runs more slowly during electrophoresis 
because there is more friction associated with a long strand of DNA than with the 
balled up circular version of the same molecule.  More surface area results in 
more molecular interaction at the surface.  Above the cut plasmid is what is 
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called a “smear”.  The smear is caused by the genomic contamination and is the 
result of the restriction enzyme cutting it into many different size molecules.   
For our purposes, we used the program to evaluate the amount of DNA present 
in each band relative to other bands.  Because the amount of DNA is directly 
proportional to the amount of fluorescence, the software can quantify the amount 
of DNA as a function of the pixel density. 
 
 
 
Figure 33.  Defined Density Boxes. 
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Table 1. Raw Density Data from VisionWorksLS Software.  The “Total Raw 
Density” refers to the number of white pixels in a particular boxed region.  This is 
the value used to calculate DNA quantities 
 
To calculate the percent genomic contamination in the purified plasmid sample, 
the density of the genomic DNA was divided by the total DNA (supercoil plus 
genomic).  The ratio of supercoil to linearized plasmid is an indication of the 
condition of the supercoil. 
In order to validate the reproducibility of the software-analyzed protocol, three 
sets of purified plasmids were electrophoresed at three different volumes.  Each 
set was evaluated for both linearity of quantity vs. volume, and the variance of 
percent genomic contamination at 95% confidence. 
 
 
 
Region Total Density 
Total 
Background 
Mean 
Density 
Mean 
Background 
Total Raw 
Density 
Mean Raw 
Density 
1 37050.3367 70099.5005 14.4728 27.3826 106816 41.725 
2 240366.2647 70099.5005 93.8931 27.3826 310463 121.2746 
3 228948.4995 70099.5005 89.433 27.3826 299048 116.8156 
4 9536.3606 70099.5005 3.7251 27.3826 79621 31.102 
5 53103.03 70099.5005 20.7434 27.3826 123201 48.1254 
6 163776.4995 70099.5005 63.9752 27.3826 233876 91.3578 
7 135507.2388 70099.5005 52.9325 27.3826 205590 80.3086 
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Improving the Yield of the Purification Process 
With the new purity quantification technique, it became possible to accurately 
evaluate the purity and yield of the purification process.  Retains of each 
manufactured batch of purified plasmids for the last several years had been 
preserved in a freezer at -4°C.  They were easily categorized by purification kit 
type: 1) MegaPrep, 2) GigaPrep and 3) Maxicard.  For all three categories, the 
functional chemistry is the same.  MegaPrep and GigaPrep are essentially the 
same process except for a difference in the size of the filtration cartridges used to 
separate the DNA from proteins and larger cell debris.  
 
 
Figure 34.  Filtration Cartridge.  Filtration cartridge used in MegaPrep and 
GigaPrep purification processes. 
 
Cartridge 
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Table 2.  Megaprep/Gigaprep Specifications.  Specification table indicating the 
difference between Megaprep and Gigaprep purification capabilities. 
 
Maxicard is an all-inclusive automated machine that carries out the entire 
purification process – from bacteria culture to purified DNA – but on a much 
smaller scale than either MegaPrep or GigaPrep. 
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Figure 35.  Maxicard Purification Machine.   
Retains purified by each category of filtration were digested with an appropriate 
restriction enzyme, as described above, and evaluated against a multitude of 
metrics in an effort to discern any indication as to which was most appropriate for 
each type of plasmid. 
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IV. Results and Discussion 
Identification Assay 
Nearly 25 plasmid characterization files were created in Vector NTI and verified 
with their sequenced genetic code. Below are the identification validation results 
of a typical plasmid family. 
The out-sourced sequencing company returned the sequenced DNA information 
in the format below. 
 
Figure 36. Sequence Data.  The sequenced plasmid file returned by the out-
sourced company.  The “N’s” are a result of imprecision localized around the 
primers. 
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The sequence file was then imported into Vector NTI and compared to the 
expected DNA sequence file (SeqID) in Life Technologies’ database. 
 
Figure 37. SeqID File.  Above is the SeqID file against which the sequenced DNA 
is compared to. 
 
The sequenced DNA file and SeqID are compared in a VectorNTI application 
called ContigExpress, shown below. 
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Figure 38.  ContigExpress Identification Evaluation.   
The sequenced DNA matches each corresponding SeqID file.  The highlighted 
region of the plasmid is due to the frame shifts of the A/B/C versions. From these 
matches the identity of each plasmid is confirmed. 
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Purity Analysis Assay Results 
In order to determine the reproducibility of the VisionWorksLS density 
measurement software, three different volumes (250 µL, 500 µL and 1000 µL) 
were electrophoresed for three different purified plasmids.   
 
 
Figure 39.  Purity Evaluation Verification Gel.  Three different plasmids were 
evaluated, each at three different loaded quantities, in order to verify the 
reproducibility and linearity fit of the evaluation technique. 
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DNA ng loaded Total Density Type %SC %Total 
   
   Plasmid 1 1000 252344 Supercoil 
  Plasmid 1 500 169193 Supercoil 
  Plasmid 1 250 101969 Supercoil 
  Plasmid 2 1000 218039 Supercoil 
  Plasmid 2 500 136203 Supercoil 
  Plasmid 2 250 67540 Supercoil 
  Plasmid 3 1000 222855 Supercoil 
  Plasmid 3 500 104198 Supercoil 
  Plasmid 3 250 82435 Supercoil 
  Plasmid 2 1000 47703 Genomic DNA 19% 16% 
Plasmid 2 500 22647 Genomic DNA 13% 12% 
Plasmid 1 250 13165 Genomic DNA 13% 11% 
Plasmid 2 1000 82142 Genomic DNA 38% 27% 
Plasmid 2 500 38166 Genomic DNA 28% 22% 
Plasmid 2 250 16971 Genomic DNA 25% 20% 
Plasmid 3 1000 62736 Genomic DNA 28% 22% 
Plasmid 3 500 23914 Genomic DNA 23% 19% 
Plasmid 3 250 17839 Genomic DNA 22% 18% 
 
Table 3.  Purity Calculations.  Software density calculations for gel shown in 
Figure 38.   
 
Analysis on the resulting data showed satisfactory results with percent genomic 
contamination confidence intervals of 2.2%, 3.5% and 2.0% at 95% confidence, 
well within the desired 95% confidence range of 5%.  An additional regression 
analysis, shown below, on the linear fit of the data points found excellent R2 
values for the slope of DNA quantity vs. volume: 0.9806, 0.9834, 0.9647, 0.9999, 
0.9958 and 0.9572.  These values indicate a high degree linear relationship 
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between the points among each DNA type of each plasmid and further suggest 
that this analysis technique is reproducible and robust. 
 
 
Figure 40.  Pixel Density vs Volume.  This graph shows the linearity between 
pixel density and quantity of DNA. 
 
With the new Purity Analysis Assay verified for reproducibility, all the available 
plasmids from the previous year were analyzed for percent genomic 
contamination.  Using the technique described in Methods and Materials, a table 
was developed to: 1) evaluate the purity of the previous year’s product and 2) 
build a spreadsheet of data from which to evaluate individual parameter 
contribution to yield and percent genomic contamination. 
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N
a
m
e 
HF 
Enzyme 
Media 
type 
Yield (ug) % g 
DNA 
SC/Linear Size Scale ug 
DNA/g 
cells 
A BamHI LB 750 9% 0.98 5500 MC 2532 
B BamHI TB 7240 3% 1.02 3890 GIGA 724 
C BamHI TB 6420 10% 1.91 3890 GIGA 321 
D BamHI TB 7480 11% 1.13 3890 GIGA 748 
E BamHI TB 9000 17% 1.47 3890 GIGA 450 
F BamHI TB 6127 11% 0.34 3890 GIGA 306 
G BamHI TB 8400 19% 1.43 3890 GIGA 420 
H BamHI TB 13550 5% 0.89 3890 GIGA 678 
I BamHI TB 13550 11% 0.83 3890 GIGA 678 
J BamHI TB 13550 10% 0.76 3890 GIGA 678 
K BamHI TB 13550 9% 0.75 3890 GIGA 678 
L BamHI TB 13550 7% 0.85 3890 GIGA 678 
M BamHI CW 14600 11% 0.81 3890 GIGA 1502 
N BamHI TB 9150 14% 1.34 3890 GIGA 458 
O EcoRI LB 1615 26% 0.96 4102 MEGA 508 
P EcoRI LB 995 8% 0.77 4102 MEGA 332 
Q EcoRI LB 435 14% 1.51 4102 MEGA 146 
R EcoRI LB 1836 21% 1.05 4102 MEGA 291 
 
Table 4.  Plasmid Characterization.  Abbreviated version of the table used to 
discern suggested parameter effects on yield and purity.  From this table, 
patterns were suggested, hypotheses were developed, and experiments were 
designed to test those hypotheses.  
 
The Plasmid Characterization Table suggested a few trends.  The strongest 
suggestion was that the size of the plasmid had an effect on purity.   
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Figure 41. Genomic Contamination vs Plasmid Size (bp).  This graph suggests 
the larger plasmids have lower contamination. 
 
One explanation for this trend is that larger plasmids have more negative charge 
to attach to the positively charged purification column, resulting in a greater 
degree of purification.  This trend may be useful in predicting purity of different 
size plasmids; however, the size of the plasmid is determined by the proteins 
coded in the DNA and cannot be altered to improve purity. 
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The data in Figure 41 also indicated a possible correlation between the amount 
of bacteria culture which was purified and the size of the purification columns 
used during purification.    
 
 
Figure 42. Genomic Contamination vs Purification Scale.  This table suggests the 
GigaPrep purification scale achieves the least contamination. 
 
The MaxiCard (MC) purified plasmids had the lowest contamination; however, 
they always use the same volume and concentration of bacteria, which is 
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significantly lower than the GigaPrep and MegaPrep purified plasmids.  
Unfortunately, MaxiCard purification cannot be scaled up to support the high 
volume purification requirement of most plasmids.  Between the two scales of 
purification which can support high volume production, the data indicate Giga is 
better than Mega.  As with most types of filters, GigaPrep and MegaPrep 
purification columns can be over-loaded.  GigaPrep is the larger of the two and 
can most likely support higher volumes of media before reaching its over-load 
threshold.  This reasoning led to the hypothesis that increasing amounts of 
bacteria to be purified results in an increasing level of contamination.  To test this 
hypothesis, plasmids were purified at varying quantities using the same scale of 
purification, and evaluated for trends between quantity of bacteria purified and 
genomic contamination level. 
 
Yield Assay 
Based on the suggested correlations in Table 4, varying quantities of bacteria 
were purified using MegaPrep kits to provide insight into the correlation between 
bacteria quantity and purity.   
Two different plasmids were purified at 4 different quantities, shown in Table 5, in 
an effort to evaluate the effect of the amount of bacteria and DNA purified on 
purity. 
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PBAD HIS B PBAD GIII B 
Culture (mL) 500 750 1000 1250 750 850 900 1000 
Bacteria (g) 2.69 4.74 5.57 9.23 3.94 5.35 5.79 5.78 
DNA Yield (ug) 408 1590 1000 680 3170 3480 7940 7940 
Yield/Bacteria 152 335 180 74 805 650 1371 1374 
% gDNA 11 18 13 15 11 21 17 17 
 
Table 5. GigaPrep Purity and Yield Assay Results.  “Culture” is the volume of 
bacteria culture.  “Bacteria” is the mass of bacteria in the culture.  “DNA Yield” is 
the mass of DNA resulting from the purification process. “% gDNA” is the percent 
of total DNA which is genomic. 
 
To help provide perspective, the results from Table 5 were graphed as purity vs 
the raw amount of DNA yielded, and purity vs the ratio of DNA yielded over mass 
of bacteria purified.  The first graph is the most direct measurement of how the 
amount of DNA purified affected the quality of purification.  The second graph 
illustrates how purity and the density of DNA in the bacteria are related. 
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Figure 43. MegaPrep Purity vs Bacteria Quantity. 
 
There appears to be a trend of increasing percent genomic contamination as 
amount of DNA purified increases.  This corroborates the theory that the charged 
column used to separate the DNA from the protein and RNA loses its 
effectiveness as it approaches a saturation point. 
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Figure 44.  MegaPrep Purity vs Efficiency. 
 
The ratio of DNA yielded over bacteria purified was initially looked at as an 
indication of the efficiency of the purification process.  Except for the outlier at 
approximately 800, the % genomic contamination seems to be increasing with 
efficiency.  However, the amount and type of DNA produced by the bacteria can 
play as large a role here as the effectiveness of the purification process.  For 
example, different plasmids replicate at different rates relative to the host cell’s 
genomic DNA.  This means that different plasmids result in varying amounts of 
plasmid DNA relative to genomic DNA before the purification process begins.  
Also, given an equal plasmid replication rate relative to the genomic replication 
rate, an 8K bp plasmid will have half the genomic contamination of a 4K bp 
plasmid.  Even though the number of plasmids is the same, because the 
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measurement is based on the quantity of constituent amino acids, not the 
number of plasmids themselves, the level of genomic contamination will differ. 
Four plasmids were purified using the MaxiCard purification machine.  The 
results are shown in Table 6.  Because this machine requires a specific volume 
and concentration, these values are the same for all four plasmids.  This 
consistency provided an opportunity to investigate the effect of plasmid size while 
controlling volume and concentration. 
 
 
PDEST40#1 PDEST40#2 PEF5 PBADHIS 
Size (bp) 7100 7100 7500 4100 
Culture (mL) 125 125 125 125 
Bacteria (g) 0.275 0.275 0.275 0.275 
DNA Yield (ug) 609 766 890 23 
Yield/Bacteria 2215 2785 3236 84 
% gDNA 9 24 6 13 
 
Table 6. MaxiCard Purity and Yield Assay Results. 
 
The graphed results show a trend of decreasing genomic contamination as 
efficiency increase, except for the outlier at 24%.  This data suggests a possible 
trend, but more data points are needed to a statistically significant trend. 
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Figure 45. MaxiCard Purity vs Efficiency. 
 
 
Figure 46.  MaxiCard Purity vs Plasmid Size. 
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As with the MegaPrep purified plasmids, genomic contamination, except for one 
data point, seems to decrease as plasmid size increases.  This is possibly due to 
more attractive forces between the purification column and the plasmid due to 
the increased number of base pairs; or the result of a larger plasmid containing 
more DNA.  The larger plasmid, given the same number of plasmid molecules 
and same amount of genomic DNA, will always have a lower level of genomic 
contamination. 
Overall, the data suggests purity is most significantly affected by both purification 
scale and plasmid size.  However, none of the experiments have enough data 
points to validate these theories with statistical significance.  Further experiments 
are needed to confirm this hypothesis. 
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V. Conclusion and Future Works 
Identification Assay 
The new protocol for confirming the correct identity of the purified plasmid is an 
improvement in many ways.  The new method is simpler, more robust and less 
expensive. There are no inconclusive results due to false negatives and 
methylation, and the unstable restriction enzymes have been obviated.  
Compared to the old paradigm, there is essentially zero ambiguity of a correct 
match.   
While currently very effective, an internal control sequence within the plasmid 
may be worth investigating.  In the event that there is a bad sequencing reaction 
or bad DNA, a control sequence would create a secondary control.  Also, it may 
be worth looking into an alternative unique region for comparison. 
 
Purity Assay 
The new purity evaluation process is a vast improvement over the extreme 
ambiguity and variability of the previous method.  However, the amount of time 
that the DNA is soaked in the stain, and the time it is de-stained is not regulated.  
Consistent staining would improve the probability that the DNA in each gel 
interacts equally with the EtBr.  Different types of stains could possibly optimize 
the consistency and speed of the process as well. 
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Yield Assay 
The yield assay suggested some interesting trends with regard to the most 
significant factors affecting genomic contamination.  While plasmid size and 
purification scale seem to play a large role and should be further investigated, it 
would be useful to research the replication rate of different plasmids relative to 
the host cell chromosome.  This relative replication rate would provide insight into 
the ratio of genomic DNA to plasmid DNA, inherent in the biology, which certainly 
affects the yield of the purification process. 
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